Data from EMA (European Medicines Agency) - Curated by Marshall Pearce - Last updated 28 November 2017

Indication(s)

Neuropathic pain
Pregabalin Accord is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy
Pregabalin Accord is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised anxiety disorder
Pregabalin Accord is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Bedwetting

Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting.

+ 7 more

Acute and Advanced Heart Failure

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

+ 3 more

Type 2 Diabetes

Type 2 Diabetes

View the latest epidemiology data, patient perspectives, ADA and EASD recommendations, treatment options and more.

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/004024
Orphan designation No
Date First Approved 28-08-2015
Type Medicinal product subject to medical prescription
Marketing authorisation holder Accord Healthcare Limited